Loading company…
Sisu Pharma develops drug treatments for prostate cancer.
Founded in 2019, Sisu Pharma develops drug treatments for cancer, including prostate cancer, and its work includes the HI-LiTe platform focused on heat shock factor 1. The company was founded and led by CEO Dr. Sean O'Brien. It raised USD 1.7 million in seed funding from Viva Ventures Biotech in October 2017.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in